ANI Pharmaceuticals announced the launch of Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg.
ANI’s Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg are the generic version of the Reference Listed Drug (RLD) Compazine® and were developed in collaboration with Biophore India Pharmaceuticals. The current annual U.S. market for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg is approximately $30M, according to IQVIA/IMS Health, a healthcare data and analytics provider.